• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during pregnancy and breastfeeding is a challenge for women suffering from the condition. There is a lack of information about how long-term exposure to these medications may affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological disorders such as impaired vision or hearing seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should consider the benefits of taking it versus the risks to the baby. The doctors don't have the information to make unambiguous recommendations however they can provide information on the risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not have an increased risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a large population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy, and those who did not. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure accurate case classification and to limit the chance of bias.

However, the researchers' study was not without its flaws. In particular, they were not able to differentiate the effects of the medication from the effects of the underlying disorder. This limitation makes it difficult to know whether the small differences observed in the exposed groups are due to the use of medication or the confounding effect of comorbidities. Researchers also did not examine long-term outcomes for offspring.

The study found that babies whose mothers had taken ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU) as compared to those whose mothers did not use any medication during pregnancy, or had stopped taking their medication before or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases didn't appear to be influenced by the type of medication that was used during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during early pregnancy may be offset by the greater benefits for both mother and child of continuing treatment for the woman's condition. Physicians should speak with their patients about this issue and as much as possible, assist them develop coping skills that can lessen the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and treated with medication, the question of whether to keep or discontinue treatment during pregnancy is one that more and more doctors have to face. These decisions are usually taken without clear and authoritative evidence. Instead, physicians must consider their own expertise, the experience of other doctors, and the research on the topic.

The issue of risk to the infant can be difficult to determine. A lot of studies on this subject are based on observations rather than controlled research, and their conclusions are often contradictory. In addition, most studies limit their analysis to live births, which can underestimate severe teratogenic effects that result in abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these limitations by looking at data from both live and deceased births.

The conclusion: While certain studies have demonstrated a positive association between ADHD medications and the risk of certain birth defects, others have not found any evidence of a link, and most studies show a neutral or even slightly negative impact. In the end, a careful risk/benefit assessment must be done in each situation.

For a lot of women with ADHD and ADD, the decision to stop medication is difficult, if not impossible. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of being isolated. A decrease in medication could also impact the ability to drive safely and perform work-related tasks, which are essential aspects of normal life for people with ADHD.

She suggests that women who are unsure whether to take the medication or discontinue it due to pregnancy educate family members, colleagues, and acquaintances about the condition, its impact on daily functioning and the advantages of staying on the current treatment regimen. In addition, educating them can help the woman feel supported when she is struggling with her decision. It is important to remember that certain medications are able to be absorbed through the placenta therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug can be transferred to the infant.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows, so do concerns about the effects that the drugs could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. Researchers used two huge data sets to study over 4.3 million pregnancy and determine if stimulant medication use increased the risk of birth defects. While the overall risk remains low, the scientists did find that first-trimester exposure to ADHD medicines was associated with an increased risk of certain heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study could not discover any connection between early use of medication and other congenital anomalies like facial deformities or club feet. The results are in the same vein as previous studies which showed the existence of a slight, but significant increase in the number of cardiac malformations among women who started taking ADHD medication prior to the time of pregnancy. This risk increased in the latter half of pregnancy, as many women begin to discontinue their prescribe adhd medication medications.

Women who took Safest Adhd Medication For Adults (Www.Stes.Tyc.Edu.Tw) medications during the first trimester of their pregnancy were also more likely to have caesarean section, low Apgar score after delivery and a baby who required breathing assistance during birth. However the authors of the study were unable to eliminate bias due to selection by restricting the study to women who did not have other medical issues that could be a contributing factor to these findings.

The researchers hope their study will serve to inform the clinical decisions of doctors who see pregnant women. They advise that while the discussion of the risks and benefits is crucial however, the decision to stop or continue treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors also warn that, while stopping the medication is an option, it is not an option that is recommended due to the high prevalence of depression and other mental health issues for women who are expecting or recently postpartum. Additionally, the research suggests that women who decide to stop taking their medication for adhd and anxiety are more likely to have a difficult time getting used to life without them after the birth of their baby.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women suffering from ADHD may face a lot of challenges when they must manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to new routines. Therefore, many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk at a low level. The rate of exposure to medication will differ based on dosage the medication is administered, its frequency and time of day. In addition, various medications enter the baby’s system through the gastrointestinal tract or breast milk. The impact of these medications on a newborn's health is not completely known.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the lack of research. This is a complicated decision for the patient, who must balance the benefits of keeping her medication with the potential risks to the foetus. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with mild adhd medication and whether they plan or are taking to take medication during the perinatal time.

Numerous studies have proven that women can continue to take their ADHD medication in a safe manner while breastfeeding and during pregnancy. In response, a rising number of patients are opting to do this. They have concluded through consultation with their doctors that the benefits of retaining their current medication outweigh any risk.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation is also required to help women with ADHD recognize their symptoms and the underlying disorder and learn about treatments and to reinforce existing coping strategies. This should be a multidisciplinary effort with the GPs, obstetricians, and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, as well as monitoring for signs of deterioration and, if needed modifications to the medication regime.